Gilead Sciences
Finanzas
Cuenta de resultados
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Ebitda | 13.982,0 | 13.056,0 | 12.495,0 |
| EBIT | 9.802,0 | 10.953,0 | 11.932,0 |
| Impuestos | 1.247,0 | 1.248,0 | 2.077,0 |
| Beneficio neto | 6.225,0 | 4.592,0 | 5.665,0 |
| Beneficio por acción (Importe) | 4,9562 | 3,6589 | 4,5392 |
| Nota: Cifras en millones. | |||
Activo
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Efectivo y equivalentes | 6.085,0 | 5.412,0 | 5.338,0 |
| Cuentas a cobrar | 4.660,0 | 4.777,0 | 4.493,0 |
| Existencias | 1.787,0 | 1.507,0 | 1.618,0 |
| Total activo corriente | 16.085,0 | 14.443,0 | 14.772,0 |
| Inmovilizado | 5.898,0 | 5.980,0 | 5.663,0 |
| Fondo de comercio | 8.314,0 | 8.314,0 | 8.332,0 |
| Otro activo no corriente | 3.215,0 | 2.929,0 | 2.886,0 |
| Activos totales | 62.125,0 | 63.171,0 | 67.952,0 |
| Nota: Cifras en millones. | |||
Pasivo
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Pasivo corriente | 39.376,0 | 41.962,0 | 46.888,0 |
| Deuda a largo plazo | 23.189,0 | 22.957,0 | 25.179,0 |
| Otro pasivo no corriente | 2.773,0 | 4.628,0 | 5.254,0 |
| Fondos propios | 22.833,0 | 21.240,0 | 21.069,0 |
| Deuda neta | 18.571,0 | 17.705,0 | 16.145,0 |
| Nota: Cifras en millones. | |||
Ratios
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Dividendo por acción (Importe) | 2,8400 | 2,9200 | 3,0000 |
| Pay out (%) | 0,5730% | 0,7980% | 0,6609% |
| PER (veces) | 12,860 | 11,116 | 12,724 |
| Valor en libros por acción (Importe) | 16,801 | 17,032 | 18,325 |
| Flujo de caja por acción (Importe) | 9,0206 | 7,1885 | 6,3640 |
| Capitaliación de mercado (Mill.) | 91.080,7 | 107.099,8 | 114.818,4 |
| Empleados | 14.400,0 | 17.000,0 | 18.000,0 |
| Nota: Datos en euros | |||
| Nota: Los datos del año actual y los próximos son estimaciones de S&P Global. | |||